Professor Eric Caumes, infectious disease specialist and advocate of vaccines has this to say about the Pfizer mrna vaccine.

“As I read the 53 pages, something struck me. I have never seen such a high frequency of adverse events for a vaccine."
"Take the example of fever. It can occur transiently after an injection; it is classic. But here, 15.8 percent of 18- to 55-year-olds had a fever of 38 degrees Celsius or higher within seven days after the second injection. And 45 percent had to take medication for fever or pain"
Another 55 percent had headaches and 62 percent were tired. No, really, that's much too much, perhaps there's a problem … ” Caumes said.
Caumes was asked about the two patients with allergies who suffered from severe side effects.

He said “I'm surprised because these adverse reactions are not listed in the U.S. drug agency document, which is my only source," he said. "This confirms that we should not rush.”
“Not only is there a lack of information, but these injections based on genetic material (messenger RNA) have never passed the commercialization stage until now," Caumes said.
"Perhaps they [RNA vaccines] are revolutionary, but I want proof of their reliability, otherwise it is tantamount to placing blind trust in industry.”
Caumes repeated his critique to Le Parisien, stating, “Pfizer and Moderna simply announced their success in a press release. In my career as a physician, I've never seen anything like this before. You have to realize there is still no trace of scientific publication.”
Warning that this could backfire, especially since the French government has already ordered and paid for them “without even knowing if they were safe,” he said.

"If we mess this up, the entire history of vaccinology will be discredited,” Caumes said.
You can follow @MRSS11224611.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.